A detailed history of California State Teachers Retirement System transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 33,891 shares of VERA stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,891
Previous 34,860 2.78%
Holding current value
$1.4 Million
Previous $1.26 Million 18.72%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$34.09 - $46.71 $33,033 - $45,261
-969 Reduced 2.78%
33,891 $1.5 Million
Q2 2024

Aug 14, 2024

BUY
$33.72 - $48.82 $84,333 - $122,098
2,501 Added 7.73%
34,860 $1.26 Million
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $75,862 - $250,024
5,088 Added 18.66%
32,359 $1.4 Million
Q4 2023

Feb 13, 2024

BUY
$9.29 - $16.0 $2,303 - $3,968
248 Added 0.92%
27,271 $419,000
Q3 2023

Nov 14, 2023

BUY
$13.71 - $19.64 $216,288 - $309,840
15,776 Added 140.27%
27,023 $370,000
Q2 2023

Aug 21, 2023

BUY
$6.11 - $17.83 $19,411 - $56,645
3,177 Added 39.37%
11,247 $180,000
Q1 2023

May 09, 2023

SELL
$5.41 - $18.3 $57,492 - $194,474
-10,627 Reduced 56.84%
8,070 $62,000
Q4 2022

Feb 14, 2023

BUY
$15.74 - $22.19 $5,697 - $8,032
362 Added 1.97%
18,697 $361,000
Q3 2022

Nov 18, 2022

SELL
$13.27 - $22.31 $2,906 - $4,885
-219 Reduced 1.18%
18,335 $391,000
Q2 2022

Aug 15, 2022

BUY
$12.82 - $23.4 $162,865 - $297,273
12,704 Added 217.16%
18,554 $253,000
Q1 2022

May 16, 2022

BUY
$17.8 - $28.06 $7,725 - $12,178
434 Added 8.01%
5,850 $137,000
Q4 2021

Feb 15, 2022

BUY
$15.01 - $35.8 $24,000 - $57,244
1,599 Added 41.89%
5,416 $145,000
Q3 2021

Nov 15, 2021

BUY
$13.71 - $30.6 $52,331 - $116,800
3,817 New
3,817 $66,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.12B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.